Regeneron Pharmaceuticals, Inc.

CHARLES SCHWAB INVESTMENT MANAGEMENT INC REGN

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

778,001

Value ($000)

600,516

Weight

0.1%

2013 Q4 - 2025 Q4 (28 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	600,516	0.1%	778,001	12/31/2025
2025 Q3	11/10/2025	424,832	0.1%	755,565	9/30/2025
2025 Q2	8/12/2025	378,143	0.1%	720,273	6/30/2025
2025 Q1	9/15/2025	448,045	0.1%	706,440	3/31/2025
2024 Q4	2/6/2025	495,639	0.1%	695,799	12/31/2024
2024 Q3	11/12/2024	707,759	0.1%	673,261	9/30/2024
2024 Q2	8/12/2024	695,532	0.1%	661,762	6/30/2024
2024 Q1	5/9/2024	614,284	0.1%	638,223	3/31/2024
2023 Q4	2/6/2024	545,081	0.1%	620,616	12/31/2023
2023 Q3	11/8/2023	492,178	0.1%	598,058	9/30/2023
2023 Q2	8/10/2023	431,150	0.1%	600,036	6/30/2023
2023 Q1	5/12/2023	489,390	0.1%	595,604	3/31/2023
2022 Q4	2/13/2023	423,474	0.1%	586,943	12/31/2022
2022 Q3	11/14/2022	394,725	0.1%	573,003	9/30/2022
2022 Q2	8/15/2022	337,217	0.1%	570,462	6/30/2022
2022 Q1	5/13/2022	392,607	0.1%	562,136	3/31/2022
2021 Q4	2/11/2022	351,311	0.1%	556,294	12/31/2021
2021 Q3	11/16/2021	320,460	0.1%	529,528	9/30/2021
2021 Q2	8/16/2021	281,998	0.1%	504,883	6/30/2021
2021 Q1	5/17/2021	236,471	0.1%	499,790	3/31/2021
2020 Q4	2/16/2021	249,357	0.1%	516,149	12/31/2020
2020 Q3	11/13/2020	285,580	0.1%	510,164	9/30/2020
2020 Q2	8/20/2020	294,066	0.1%	471,523	6/30/2020
2020 Q1	5/15/2020	174,367	0.1%	357,097	3/31/2020
2019 Q4	2/7/2020	134,015	0.1%	356,916	12/31/2019
2014 Q2	7/30/2014	46,422	0.1%	164,342	6/30/2014
2014 Q1	4/29/2014	46,702	0.1%	155,526	3/31/2014
2013 Q4	2/14/2014	41,750	0.1%	151,684	12/31/2013